Apnimed, Inc.
Support and Resistance Levels
Past performance
News About APMD
All events for APMD
All deals for APMD
Financial Ratios
Financial Statements
APMD vs Sector & Peers
About Apnimed, Inc.
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts. Website apnimed.com
Headquarters Cambridge, MA, US